Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Glucocorticoids Lower Risk of Severe Infliximab Infusion Reactions
Link ID 924
Title Glucocorticoids Lower Risk of Severe Infliximab Infusion Reactions
Url http://www.medscape.com/viewarticle/566071?src=rss
Description Low-dose glucocorticoid therapy reduces the risk of treatment-limiting infusion reactions to infliximab in patients with rheumatoid arthritis, Swedish researchers found in a retrospective study. They also found evidence that severe infusion reactions have become significantly less common in recent years. Reuters Health Information
Category Articles > Internal Medicine
Keywords
Date Nov 18, 2007
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Internal Medicine
1. Markers of Arterial Stiffness Predict Decline in Memory and Concentration
  Measures of arterial stiffness — pulse pressure and pulse-wave velocity — were linked to a decline in memory and concentration in a recent study. Medscape Medical News
Category:   Articles > Internal Medicine


2. Medscape General Medicine: April 9, 1999-December 31, 2007. This Epilogue Is not an Epitaph
  Be sure to come back to see The Medscape Journal of Medicine in January 2008.
Medscape General Medicine
Category:   Articles > Internal Medicine


3. ACR 2007: Updates on Pediatric Rheumatoid Arthritis
  Advances in the management of pediatric rheumatoid arthritis as illustrated by data presented at the American College of Rheumatology 2007 Annual Meeting. Medscape Rheumatology
Category:   Articles > Internal Medicine


4. Smoking in Young Women Linked to Higher Stroke Risk
  Researchers have identified a dose-response relationship between cigarette smoking and ischemic stroke risk. Medscape Medical News
Category:   Articles > Internal Medicine


5. First-Time Generic Approvals: Trileptal, Vicoprofen, Exelon
  The FDA has approved first-time generic formulations for oxcarbazepine tablets in 150-, 300-, and 600-mg strengths; hydrocodone

bitartrate and ibuprofen tablets in a 2.5-mg/200-mg strength; and rivastigmine tartrate capsules in 1.5-, 3-, 4.5-, and 6-mg (base) strengths. Medscape Medical News
Category:   Articles > Internal Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS